{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:41:44Z","timestamp":1789944104669,"version":"4.0.1"},"reference-count":201,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2015.00090","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T13:28:09Z","timestamp":1431350889000},"source":"Crossref","is-referenced-by-count":18,"title":["The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia \u00e2\u20ac\u201c With Emphasis on Alzheimer\u00e2\u20ac\u2122s Disease"],"prefix":"10.3389","volume":"6","author":[{"given":"Dilek","family":"Inekci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte Svendsen","family":"Jonesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"key":"B1","volume-title":"World Alzheimer Report 2010","author":"Wimo","year":"2010"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1586\/ern.11.155","article-title":"Distinguishing Alzheimer\u00e2\u20ac\u2122s disease from other major forms of dementia","volume":"11","author":"Karantzoulis","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.mpmed.2012.08.012","article-title":"Dementia","volume":"40","author":"Holmes","year":"2012","journal-title":"Medicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2006.06.023","article-title":"Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?","volume":"545","author":"Borroni","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00019052-200208000-00007","article-title":"Neuropsychiatric symptoms in the dementias","volume":"15","author":"Assal","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3988\/jcn.2009.5.4.153","article-title":"Current challenges for the early detection of Alzheimer\u00e2\u20ac\u2122s disease: brain imaging and CSF studies","volume":"5","author":"Mistur","year":"2009","journal-title":"J Clin Neurol"},{"issue":"3","key":"B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u00e2\u20ac\u2122s disease: recommendations from the National Institute on Aging-Alzheimer\u00e2\u20ac\u2122s Association workgroups on diagnostic guidelines for Alzheimer\u00e2\u20ac\u2122s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"\u00e2\u20ac\u0153Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration,\u00e2\u20ac\u009d","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archneur.57.3.347","article-title":"Diagnostic accuracy of dementia with Lewy bodies","volume":"57","author":"Hohl","year":"2000","journal-title":"Arch Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/gps.2415","article-title":"\u00e2\u20ac\u0153Differentiating the frontal variant of Alzheimer\u00e2\u20ac\u2122s disease,\u00e2\u20ac\u009d","volume":"25","author":"Woodward","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"issue":"Suppl 3","key":"B11","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jalz.2010.06.004","article-title":"Biomarkers in Alzheimer\u00e2\u20ac\u2122s disease drug development","volume":"7","author":"Cummings","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nm.2221","article-title":"Biomarkers in Alzheimer\u00e2\u20ac\u2122s disease drug development","volume":"16","author":"Blennow","year":"2010","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1755-5949.2009.00104.x","article-title":"Biological marker candidates of Alzheimer\u00e2\u20ac\u2122s disease in blood, plasma, and serum","volume":"15","author":"Schneider","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u00e2\u20ac\u2122s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/078538902320322529","article-title":"Disordered proteins in dementia","volume":"34","author":"Ingelsson","year":"2002","journal-title":"Ann Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","article-title":"Cerebrospinal fluid protein biomarkers for Alzheimer\u00e2\u20ac\u2122s disease","volume":"1","author":"Blennow","year":"2004","journal-title":"NeuroRx"},{"key":"B18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u00e2\u20ac\u2122s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000141039","article-title":"Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes","volume":"26","author":"Mukaetova-Ladinska","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","article-title":"Cerebrospinal fluid biomarkers in Alzheimer\u00e2\u20ac\u2122s disease, vascular dementia and ischemic stroke patients: a critical analysis","volume":"260","author":"Kaerst","year":"2013","journal-title":"J Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M809462200","article-title":"Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies","volume":"284","author":"Igaz","year":"2009","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","article-title":"A new subtype of frontotemporal lobar degeneration with FUS pathology","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-008-0395-x","article-title":"TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD","volume":"116","author":"Roeber","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u00e2\u20ac\u2122s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"209409","DOI":"10.1155\/2012\/209409","article-title":"Will posttranslational modifications of brain proteins provide novel serological markers for dementias?","volume":"2012","author":"Wang","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u00e2\u20ac\u2122s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1749-6632.2009.04944.x","article-title":"CSF biomarkers: pinpointing Alzheimer pathogenesis","volume":"1180","author":"Mattsson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u00e2\u20ac\u2122s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000077170","article-title":"Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia","volume":"17","author":"Hampel","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u00e2\u20ac\u2122s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"6","key":"B36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","article-title":"The cerebrospinal fluid \u00e2\u20ac\u02dcAlzheimer profile\u00e2\u20ac\u2122: easily said, but what does it mean?","volume":"10","author":"Duits","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer\u00e2\u20ac\u2122s disease in patients with mild cognitive impairment","volume":"9","author":"Hampel","year":"2004","journal-title":"Mol Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and A-beta 42 predicts development of Alzheimer\u00e2\u20ac\u2122s disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen","year":"2003","journal-title":"Acta Neurol Scand Suppl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","article-title":"Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42","volume":"60","author":"Maddalena","year":"2003","journal-title":"Arch Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased-alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u00e2\u20ac\u2122s disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF \u00ce\u00b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"430.e1","DOI":"10.1016\/j.neurobiolaging.2010.12.001","article-title":"CSF-alpha-synuclein does not differentiate between parkinsonian disorders","volume":"33","author":"Aerts","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-2009-0955","article-title":"Cerebrospinal fluid \u00ce\u00b1-synuclein does not discriminate between dementia disorders","volume":"16","author":"Spies","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3233\/JAD-2010-100186","article-title":"CSF-alpha-synuclein does not discriminate dementia with Lewy bodies from Alzheimer\u00e2\u20ac\u2122s disease","volume":"22","author":"Reesink","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid \u00ce\u00b1-synuclein oligomers are increased in Parkinson\u00e2\u20ac\u2122s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u00e2\u20ac\u2122s disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson\u00e2\u20ac\u2122s disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov Disord"},{"issue":"5 Suppl","key":"B50","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1016\/j.jalz.2013.10.004","article-title":"Increased CSF-alpha-synuclein levels in Alzheimer\u00e2\u20ac\u2122s disease: correlation with tau levels","volume":"10","author":"Slaets","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer\u00e2\u20ac\u2122s disease - current concepts","volume":"8","author":"Ros\u00c3\u00a9n","year":"2013","journal-title":"Mol Neurodegener"},{"key":"B52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer\u00e2\u20ac\u2122s Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","article-title":"Developing novel blood-based biomarkers for Alzheimer\u00e2\u20ac\u2122s disease","volume":"10","author":"Snyder","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1326-8-38","article-title":"Blood \u00e2\u20ac\u201c brain-barriers in aging and in Alzheimer\u00e2\u20ac\u2122s disease","volume":"8","author":"Marques","year":"2013","journal-title":"Mol Neurodegener"},{"key":"B55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-386986-9.00003-X","article-title":"The blood-brain barrier in Alzheimer\u00e2\u20ac\u2122s disease. Novel therapeutic targets and nanodrug delivery","volume":"102","author":"Sharma","year":"2012","journal-title":"Int Rev Neurobiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","article-title":"Blood-brain barrier pathology in Alzheimer\u00e2\u20ac\u2122s and Parkinson\u00e2\u20ac\u2122s disease: implications for drug therapy","volume":"16","author":"Desai","year":"2007","journal-title":"Cell Transplant"},{"key":"B57","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF00688180","article-title":"Immunodetection of the amyloid P component in Alzheimer\u00e2\u20ac\u2122s disease","volume":"78","author":"Duong","year":"1989","journal-title":"Acta Neuropathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u00e2\u20ac\u2122s disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/hbm.22390","article-title":"Plasma tau as a window to the brain-negative associations with brain ume and memory function in mild cognitive impairment and early Alzheimer\u00e2\u20ac\u2122s disease","volume":"35","author":"Chiu","year":"2014","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"B61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","article-title":"Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study","volume":"84","author":"Randall","year":"2013","journal-title":"Resuscitation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-2011-111418","article-title":"Evaluation of plasma A\u00ce\u00b2 as predictor of Alzheimer\u00e2\u20ac\u2122s disease in older individuals without dementia: a population-based study","volume":"28","author":"Hansson","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S1474-4422(06)70503-8","article-title":"Plasma Abeta in Alzheimer\u00e2\u20ac\u2122s disease-up or down?","volume":"5","author":"Zetterberg","year":"2006","journal-title":"Lancet Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"10\u00e2\u20ac\u201c11","key":"B65","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clinbiochem.2010.03.015","article-title":"Novel combinations of post-translational modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?","volume":"43","author":"Karsdal","year":"2010","journal-title":"Clin Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer\u00e2\u20ac\u2122s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e76523","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF tau and ptau biomarkers for Alzheimer\u00e2\u20ac\u2122s disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1097\/00001756-199611040-00025","article-title":"A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity","volume":"7","author":"Marques","year":"1996","journal-title":"Neuroreport"},{"key":"B69","doi-asserted-by":"publisher","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainres.2008.06.094","article-title":"Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer\u00e2\u20ac\u2122s disease","volume":"1228","author":"Rohn","year":"2008","journal-title":"Brain Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"L115","DOI":"10.1016\/S0024-3205(96)00685-6","article-title":"The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations","volume":"60","author":"Shayo","year":"1997","journal-title":"Life Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer\u00e2\u20ac\u2122s disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-8993(99)01961-7","article-title":"Peptides crossing the blood-brain barrier: some unusual observations","volume":"848","author":"Kastin","year":"1999","journal-title":"Brain Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1568007043482525","article-title":"Polypeptide delivery across the blood-brain barrier","volume":"3","author":"Pan","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2014.3741","article-title":"Serum tau fragments predict return to play in concussed professional ice hockey players","author":"Shahim","year":"2015","journal-title":"J Neurotrauma"},{"key":"B76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00221-011-2870-1","article-title":"Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells","volume":"217","author":"Brunholz","year":"2012","journal-title":"Exp Brain Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1152\/physrev.00023.2009","article-title":"Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process","volume":"90","author":"De Strooper","year":"2010","journal-title":"Physiol Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u00e2\u20ac\u2122s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol Brain"},{"key":"B79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of Tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u00e2\u20ac\u2122s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1471-4159.2003.02018.x","article-title":"Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain","volume":"87","author":"Zou","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"B82","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann Neurol"},{"issue":"1","key":"B83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000352020","article-title":"Immune activation in amyloid-\u00ce\u00b2-related angiitis correlates with decreased parenchymal amyloid-\u00ce\u00b2 plaque load","volume":"13","author":"Bogner","year":"2013","journal-title":"Neurodegener Dis"},{"issue":"4","key":"B84","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid \u00ce\u00b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies","volume":"73","author":"Piazza","year":"2013","journal-title":"Ann Neurol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-142376","article-title":"Prodromal Alzheimer\u00e2\u20ac\u2122s disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-beta autoantibodies","volume":"45","author":"Boncoraglioa","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"B86","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-2012-111796","article-title":"Aminoterminally truncated and oxidized amyloid-\u00ce\u00b2 peptides in the cerebrospinal fluid of Alzheimer\u00e2\u20ac\u2122s disease patients","volume":"29","author":"Bibl","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B87","first-page":"65","article-title":"Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer \u00e2\u20ac\u02dcs disease","volume":"20","author":"Larner","year":"1999","journal-title":"Neurobiol Aging"},{"key":"B88","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1021\/pr0703627","article-title":"Characterization of amyloid-beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry","volume":"6","author":"Portelius","year":"2007","journal-title":"J Proteome Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u00e2\u20ac\u2122s disease","volume":"120","author":"Portelius","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.2174\/138161211797416039","article-title":"Novel A\u00ce\u00b2 isoforms in Alzheimer\u00e2\u20ac\u2122s disease \u00e2\u20ac\u201c their role in diagnosis and treatment","volume":"17","author":"Portelius","year":"2011","journal-title":"Curr Pharm Des"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2009.06.002","article-title":"A novel pathway for amyloid precursor protein processing","volume":"32","author":"Portelius","year":"2011","journal-title":"Neurobiol Aging"},{"key":"B92","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2217\/bmm.09.84","article-title":"Blood-based biomarkers of Alzheimer\u00e2\u20ac\u2122s disease: challenging but feasible","volume":"4","author":"Thambisetty","year":"2010","journal-title":"Biomark Med"},{"issue":"1","key":"B93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/JAD-140156","article-title":"A-beta (1-17) is a major amyloid-beta fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer\u00e2\u20ac\u2122s disease","volume":"43","author":"Perez-Grijalba","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00c3\u00a9e","year":"2000","journal-title":"Brain Res Rev"},{"key":"B96","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol"},{"key":"B97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2008-14101","article-title":"Differential incorporation of tau isoforms in Alzheimer\u00e2\u20ac\u2122s disease","volume":"14","author":"Espinoza","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1750-3639.1999.tb00550.x","article-title":"Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick\u00e2\u20ac\u2122s disease","volume":"9","author":"Bu\u00c3\u00a9e","year":"1999","journal-title":"Brain Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/ejn.12229","article-title":"Spreading of tau pathology in Alzheimer\u00e2\u20ac\u2122s disease by cell-to-cell transmission","volume":"37","author":"Mohamed","year":"2013","journal-title":"Eur J Neurosci"},{"issue":"4","key":"B100","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-140984","article-title":"Relationship between serum levels of tau fragments and clinical progression of Alzheimer \u00e2\u20ac\u02dc s disease,\u00e2\u20ac\u009d","volume":"43","author":"Henriksen","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"B101","doi-asserted-by":"publisher","first-page":"e64990","DOI":"10.1371\/journal.pone.0064990","article-title":"An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function","volume":"8","author":"Henriksen","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"B102","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1042\/BST0381016","article-title":"Tau cleavage and tau aggregation in neurodegenerative disease","volume":"38","author":"Hanger","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"B103","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1042\/BST0380955","article-title":"Proteolytic processing of tau","volume":"38","author":"Wang","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"B104","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:23:3:189","article-title":"Apolipoprotein E","volume":"23","author":"Huang","year":"2004","journal-title":"J Mol Neurosci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","article-title":"APOE and cholesterol homeostasis in Alzheimer\u00e2\u20ac\u2122s disease","volume":"16","author":"Leduc","year":"2010","journal-title":"Trends Mol Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","article-title":"Thirty years of Alzheimer\u00e2\u20ac\u2122s disease genetics: the implications of systematic meta-analyses","volume":"9","author":"Bertram","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"B109","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","article-title":"The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE e2","volume":"37","author":"Suri","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24369","article-title":"APOE\u00ce\u00b52 is associated with milder clinical and pathological Alzheimer\u00e2\u20ac\u2122s disease","author":"Serrano-Pozo","year":"2015","journal-title":"Ann Neurol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1074\/jbc.M309475200","article-title":"Astroglial regulation of apolipoprotein E expression in neuronal cells \u00e2\u20ac\u201c implications for Alzheimer\u00e2\u20ac\u2122s disease","volume":"279","author":"Harris","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"B112","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2009.10.040","article-title":"Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency","volume":"210","author":"Tibolla","year":"2010","journal-title":"Atherosclerosis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/01.STR.27.8.1333","article-title":"Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy","volume":"27","author":"Greenberg","year":"1996","journal-title":"Stroke"},{"key":"B114","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1468-1331.2006.01360.x","article-title":"The association between apolipoprotein E and multiple sclerosis","volume":"13","author":"Pinholt","year":"2006","journal-title":"Eur J Neurol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/archneur.61.10.1579","article-title":"Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration","volume":"61","author":"Josephs","year":"2004","journal-title":"Arch Neurol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ajmg.b.30196","article-title":"Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson\u00e2\u20ac\u2122s disease","volume":"136B","author":"Martinez","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1023\/A:1007516210548","article-title":"Measurement of apolipoprotein E (apoE) in cerebrospinal fluid","volume":"25","author":"Hesse","year":"2000","journal-title":"Neurochem Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jalz.2013.03.010","article-title":"High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia","volume":"10","author":"Vijayaraghavan","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(97)13394-8","article-title":"Increased plasma apolipoprotein E (apoE) levels in Alzheimer\u00e2\u20ac\u2122s disease","volume":"223","author":"Taddei","year":"1997","journal-title":"Neurosci Lett"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","article-title":"Plasma apolipoprotein e and Alzheimer disease risk: the AIBL study of aging","volume":"76","author":"Gupta","year":"2011","journal-title":"Neurology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-3940(98)00339-5","article-title":"Serum apolipoprotein e level is not increased in Alzheimer\u00e2\u20ac\u2122s disease: the Rotterdam study","volume":"248","author":"Slooter","year":"1998","journal-title":"Neurosci Lett"},{"key":"B122","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1515\/CCLM.2000.102","article-title":"Apolipoprotein E polymorphism and serum concentration in Alzheimer\u00e2\u20ac\u2122s disease in nine European centres: the ApoEurope study. ApoEurope group","volume":"38","author":"Siest","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann Neurol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer\u00e2\u20ac\u2122s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1471-4159.2005.03295.x","article-title":"A 13 kDa carboxy-terminal fragment of ApoE stabilizes Abeta hexamers","volume":"94","author":"Wellnitz","year":"2005","journal-title":"J Neurochem"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"\u00e2\u20ac\u0153Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.,\u00e2\u20ac\u009d","volume":"24","author":"Brecht","year":"2004","journal-title":"J Neurosci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e93120","DOI":"10.1371\/journal.pone.0093120","article-title":"Extracellular proteolysis of apolipoprotein e (apoE) by secreted serine neuronal protease","volume":"9","author":"Tamboli","year":"2014","journal-title":"PLoS One"},{"key":"B128","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer\u00e2\u20ac\u2122s disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"B129","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/JMN:22:3:199","article-title":"Alpha-synuclein is expressed in different tissues during human fetal development","volume":"22","author":"Ltic","year":"2004","journal-title":"J Mol Neurosci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"\u00ce\u00b1-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356","volume":"274","author":"Jensen","year":"1999","journal-title":"J Biol Chem"},{"key":"B131","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/ana.20639","article-title":"Subgroups of Alzheimer\u00e2\u20ac\u2122s disease based on cerebrospinal fluid molecular markers","volume":"58","author":"Iqbal","year":"2005","journal-title":"Ann Neurol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"10253","DOI":"10.1523\/JNEUROSCI.0581-12.2012","article-title":"Soluble alpha-synuclein is a novel modulator of Alzheimer\u00e2\u20ac\u2122s disease pathophysiology","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"key":"B133","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.2009.197483","article-title":"Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer\u00e2\u20ac\u2122s disease","volume":"81","author":"Kasuga","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B134","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u00e2\u20ac\u2122s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson\u00e2\u20ac\u2122s disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J Neural Transm"},{"key":"B136","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.22928","article-title":"Plasma alpha-synuclein in patients with Parkinson\u00e2\u20ac\u2122s disease with and without treatment","volume":"25","author":"Duran","year":"2010","journal-title":"Mov Disord"},{"issue":"12","key":"B137","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u00e2\u20ac\u2122s disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J"},{"key":"B138","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","article-title":"Elevated levels of \u00ce\u00b1-synuclein oligomer in the cerebrospinal fluid of drug-na\u00c3\u00afve patients with Parkinson\u00e2\u20ac\u2122s disease","volume":"7","author":"Park","year":"2011","journal-title":"J Clin Neurol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000329763","article-title":"Decreased alpha-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer\u00e2\u20ac\u2122s disease patients and control subjects","volume":"31","author":"Laske","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation","volume":"170","author":"Dufty","year":"2007","journal-title":"Am J Pathol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.expneurol.2008.10.010","article-title":"T. H\u00c3\u00b6gen, G. N\u00c3\u00bcbling, H. Kretzschmar, and S. Lorenzl, \u00e2\u20ac\u0153Increased \u00ce\u00b1-synuclein aggregation following limited cleavage by certain matrix metalloproteinases,\u00e2\u20ac\u009d","volume":"215","author":"Levin","year":"2009","journal-title":"Exp Neurol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/exnr.2002.8019","article-title":"Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson\u00e2\u20ac\u2122s disease","volume":"178","author":"Lorenzl","year":"2002","journal-title":"Exp Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1096\/fj.06-5865com","article-title":"A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation","volume":"21","author":"Kim","year":"2007","journal-title":"FASEB J"},{"key":"B144","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1440-1819.2000.00731.x","article-title":"Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer\u00e2\u20ac\u2122s disease and Parkinson\u00e2\u20ac\u2122s disease","volume":"54","author":"Ogawa","year":"2000","journal-title":"Psychiatry Clin Neurosci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e53250","DOI":"10.1371\/journal.pone.0053250","article-title":"Low CSF levels of both \u00ce\u00b1-synuclein and the \u00ce\u00b1-synuclein cleaving enzyme neurosin in patients with synucleinopathy","volume":"8","author":"Wennstr\u00c3\u00b6m","year":"2013","journal-title":"PLoS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-4-9","article-title":"\u00ce\u00b1-Synuclein and neuronal cell death","volume":"4","author":"Cookson","year":"2009","journal-title":"Mol Neurodegener"},{"key":"B147","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11910-009-0052-3","article-title":"TDP-43 and frontotemporal dementia","volume":"9","author":"Hu","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B148","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1192\/bjp.180.2.140","article-title":"Frontotemporal dementia","volume":"180","author":"Snowden","year":"2002","journal-title":"Br J Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"B150","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B151","first-page":"147","article-title":"TDP-43 in aging and Alzheimer\u00e2\u20ac\u2122s disease - a review","volume":"4","author":"Wilson","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","article-title":"TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"65","author":"Steinacker","year":"2008","journal-title":"Arch Neurol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00401-009-0594-0","article-title":"Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration","volume":"118","author":"Foulds","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","article-title":"TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer\u00e2\u20ac\u2122s disease and frontotemporal lobar degeneration","volume":"116","author":"Foulds","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.bbamcr.2014.01.010","article-title":"Reduced cellular Ca2+ availability enhances TDP-43 cleavage by apoptotic caspases","volume":"1843","author":"De Marco","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/brain\/awn061","article-title":"Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions","volume":"131","author":"Mackenzie","year":"2008","journal-title":"Brain"},{"issue":"Pt 1","key":"B158","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1242\/jcs.110.15.1741","article-title":"TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling","volume":"110","author":"Zinszner","year":"1997","journal-title":"J Cell Sci"},{"key":"B159","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1093\/emboj\/17.15.4442","article-title":"TLS\/FUS, a pro-oncogene inved in multiple chromosomal translocations, is a novel regulator of BCR\/ABL-mediated leukemogenesis","volume":"17","author":"Perrotti","year":"1998","journal-title":"EMBO J"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1038\/sj.onc.1203048","article-title":"Human POMp75 is identified as the pro-oncoprotein TLS\/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation","volume":"18","author":"Bertrand","year":"1999","journal-title":"Oncogene"},{"key":"B161","doi-asserted-by":"publisher","first-page":"34337","DOI":"10.1074\/jbc.274.48.34337","article-title":"Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS\/FUS and is able to promote D-loop formation","volume":"274","author":"Baechtold","year":"1999","journal-title":"J Biol Chem"},{"key":"B162","doi-asserted-by":"publisher","first-page":"27761","DOI":"10.1074\/jbc.273.43.27761","article-title":"Oncoprotein TLS interacts with serine-arginine proteins inved in RNA splicing","volume":"273","author":"Yang","year":"1998","journal-title":"J Biol Chem"},{"key":"B163","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2121-9-37","article-title":"The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and invement in cell spreading and stress response","volume":"9","author":"Andersson","year":"2008","journal-title":"BMC Cell Biol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-012-1043-z","article-title":"Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion","volume":"125","author":"Mitchell","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s10038-007-0124-7","article-title":"The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells","volume":"52","author":"Yoshida","year":"2007","journal-title":"J Hum Genet"},{"key":"B166","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2010.08.004","article-title":"Cuervo1 AM","volume":"39","author":"Bandyopadhyay","year":"2010","journal-title":"Identification of regulators of chaperone-mediated autophagy Mol Cell"},{"key":"B167","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.brainres.2006.04.021","article-title":"Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy","volume":"1095","author":"Emirandetti","year":"2006","journal-title":"Brain Res"},{"key":"B168","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(sici)1098-1136(200007)31:169::aid-glia703.0.co;2-w","article-title":"Comparative anatomy of the cerebellar cortex in mice lacking vimentin, GFAP, and both vimentin and GFAP","volume":"31","author":"Gim\u00c3\u00a9nez","year":"2000","journal-title":"Glia"},{"key":"B169","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.1074\/jbc.274.34.23996","article-title":"Intermediate filament protein partnership in astrocytes","volume":"274","author":"Eliasson","year":"1999","journal-title":"J Biol Chem"},{"key":"B170","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/0022-3468(90)90563-O","article-title":"Immunocytochemical characterization of supporting cells in the enteric nervous system in Hirschsprung\u00e2\u20ac\u2122s disease","volume":"25","author":"Kato","year":"1990","journal-title":"J Pediatr Surg"},{"key":"B171","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1097-4547(19970401)48:1%3C53::AID-JNR5%3E3.0.CO;2-D","article-title":"Detection of the peripheral nervous system (PNS)-type glial fibrillary acidic protein (GFAP) and its mRNA in human lymphocytes","volume":"48","author":"Riol","year":"1997","journal-title":"J Neurosci Res"},{"key":"B172","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jnen\/60.5.449","article-title":"Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo","volume":"60","author":"Hainfellner","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/lt.21436","article-title":"Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C","volume":"14","author":"Carotti","year":"2008","journal-title":"Liver Transpl"},{"key":"B174","doi-asserted-by":"publisher","first-page":"289e300","DOI":"10.1002\/glia.20243","article-title":"Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton","volume":"52","author":"Roelofs","year":"2005","journal-title":"Glia"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e7663","DOI":"10.1371\/journal.pone.0007663","article-title":"Specific human astrocyte subtype revealed by affinity purified GFAP+1 antibody","volume":"4","author":"Middeldorp","year":"2009","journal-title":"Unpurified serum cross-reacts with neurofilament-L in Alzheimer PLoS One"},{"key":"B176","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","article-title":"Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer\u00e2\u20ac\u2122s disease","volume":"35","author":"Kamphuis","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B177","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1474-9726.2010.00556.x","article-title":"Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta","volume":"9","author":"van den Berge","year":"2010","journal-title":"Aging Cell"},{"key":"B178","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1091\/mbc.E08-03-0284","article-title":"Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association","volume":"19","author":"Perng","year":"2008","journal-title":"Mol Biol Cell"},{"key":"B179","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/glia.20475","article-title":"Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform","volume":"55","author":"Blechingberg","year":"2007","journal-title":"Glia"},{"key":"B180","doi-asserted-by":"publisher","first-page":"29983","DOI":"10.1074\/jbc.M112121200","article-title":"new splice variant of glial fibrillary acidic protein","volume":"277","author":"Nielsen","year":"2002","journal-title":"GFAP epsilon, interacts with the presenilin proteins J Biol Chem"},{"key":"B181","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/35017108","article-title":"Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1","volume":"2","author":"Zhang","year":"2000","journal-title":"Nature Cell Biol"},{"issue":"21","key":"B182","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing","volume":"18","author":"Wang","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B183","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000217729","article-title":"Population variation in Glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia","volume":"27","author":"Wharton","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B184","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1440-1819.1998.tb02706.x","article-title":"quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer\u00e2\u20ac\u2122s disease, normal controls and non-Alzheimer neuropsychiatric diseases","volume":"52","author":"Muramori","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/pmic.200300456","article-title":"Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer\u00e2\u20ac\u2122s disease","volume":"3","author":"Porchet","year":"2003","journal-title":"Proteomics"},{"key":"B186","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol Aging"},{"key":"B187","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1471-4159.1997.68010430.x","article-title":"The tau protein in human cerebrospinal fluid in Alzheimer\u00e2\u20ac\u2122s disease consists of proteolytically derived fragments","volume":"68","author":"Johnson","year":"1997","journal-title":"J Neurochem"},{"key":"B188","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"B189","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000050753","article-title":"The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer\u00e2\u20ac\u2122s disease patients and correlates with severity of dementia","volume":"46","author":"Fukuyama","year":"2001","journal-title":"Eur Neurol"},{"issue":"2","key":"B190","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults.,\u00e2\u20ac\u009d","volume":"51","author":"Rosengren","year":"1994","journal-title":"J Neurosci Methods"},{"issue":"3","key":"B191","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u00e2\u20ac\u2122s disease and Creutzfeldt-Jakob disease","volume":"17","author":"Jesse","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"B192","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-2010-090649","article-title":"CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease","volume":"21","author":"Van Eijk","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"B193","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1373\/clinchem.2009.134122","article-title":"Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients","volume":"56","author":"Brouns","year":"2010","journal-title":"Clin Chem"},{"issue":"10","key":"B194","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/01.STR.22.10.1254","article-title":"Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction","volume":"22","author":"Aurell","year":"1991","journal-title":"Stroke"},{"issue":"4","key":"B195","doi-asserted-by":"publisher","first-page":"e33606","DOI":"10.1371\/journal.pone.0033606","article-title":"Csf-biomarkers in olympic boxing: diagnosis and effects of repetitive head trauma","volume":"7","author":"Neselius","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"B196","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/PCC.0b013e3181e8b32d","article-title":"Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum","volume":"12","author":"Fraser","year":"2011","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"B197","doi-asserted-by":"publisher","first-page":"e62101","DOI":"10.1371\/journal.pone.0062101","article-title":"Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases","volume":"8","author":"Mayer","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"B198","doi-asserted-by":"publisher","first-page":"e00125","DOI":"10.1042\/AN20130032","article-title":"Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation","volume":"5","author":"Chen","year":"2013","journal-title":"ASN Neuro"},{"key":"B199","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2353\/ajpath.2006.050798","article-title":"Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer\u00e2\u20ac\u2122s disease brain","volume":"168","author":"Mouser","year":"2006","journal-title":"Am J Pathol"},{"issue":"2","key":"B200","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0006-8993(00)02180-6","article-title":"Rapid increase in immunoreactivity to GFAP in astrocytes in vitro induced by acidic pH is mediated by calcium influx and calpain I","volume":"864","author":"Lee","year":"2000","journal-title":"Brain Res"},{"key":"B201","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4137\/BMI.S9873","article-title":"Characterization of antibodies that detect human GFAP after traumatic brain injury","volume":"7","author":"Zoltewicz","year":"2012","journal-title":"Biomark Insights"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T20:34:40Z","timestamp":1651955680000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.frontiersin.org\/Neurodegeneration\/10.3389\/fneur.2015.00090\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":201,"URL":"https:\/\/doi.org\/10.3389\/fneur.2015.00090","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}